Diagnostic challenges in parkinsonism

References

• Abdo WF, van de Warrenburg BP, Burn DJ, Quinn NP, Bloem BR. The clinical approach to movement disorders. Nat. Rev. Neurol.>6, 29–37 (2010).
   PubMed Web of Science ®Google Scholar
• Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol.>56, 33–39 (1999).
   PubMedGoogle Scholar
• Litvan I, Agid Y, Calne D et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS–SPSP international workshop. Neurology>47, 1–9 (1996).
   PubMed Web of Science ®Google Scholar
• Gilman S, Wenning GK, Low PA. Second consensus statement on the diagnosis of multiple system atrophy. Neurology>71, 670–676 (2008).
   PubMed Web of Science ®Google Scholar
• Ghorayeb I, Bioulac B, Tison F. Sleep disorders in multiple system atrophy. J. Neural Transm.>112, 1669–1675 (2005).
   PubMed Web of Science ®Google Scholar
• Sadaoka T, Kakitsuba N, Fujiwara Y, Kanai R, Takahashi H. Sleep-related breathing disorders in patients with multiple system atrophy and vocal fold palsy. Sleep>19, 479–484 (1996).
   PubMed Web of Science ®Google Scholar
• Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology>47, 1184–1189 (1996).
   PubMed Web of Science ®Google Scholar
• Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology>42, 1142–1146 (1992).
   PubMed Web of Science ®Google Scholar
• Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain>125, 861–870 (2002).
   PubMed Web of Science ®Google Scholar
• Litvan I, MacIntyre A, Goetz CG et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch. Neurol.>55, 969–978 (1998).
   PubMedGoogle Scholar
• Litvan I, Goetz CG, Jankovic J et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch. Neurol.>54, 937–944 (1997).
   PubMedGoogle Scholar
• Wenning GK, Ben SY, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain>117(Pt 4), 835–845 (1994).
   PubMed Web of Science ®Google Scholar
• Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinicopathological study of 35 cases of multiple system atrophy. J. Neurol. Neurosurg. Psychiatry>58, 160–166 (1995).
   PubMed Web of Science ®Google Scholar
• Wenning GK, Tison F, Ben SY, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov. Disord.>12, 133–147 (1997).
   PubMed Web of Science ®Google Scholar
• Verny M, Jellinger KA, Hauw JJ, Bancher C, Litvan I, Agid Y. Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol.>91, 427–431 (1996).
   PubMed Web of Science ®Google Scholar
• Aerts MB, Abdo WF, Bloem BR. The ‘bicycle sign’ for atypical parkinsonism. Lancet>377, 125–126 (2011).
   PubMed Web of Science ®Google Scholar
• Abdo WF, Borm GF, Munneke M, Verbeek MM, Esselink RA, Bloem BR. Ten steps to identify atypical parkinsonism. J. Neurol. Neurosurg. Psychiatry>77, 1367–1369 (2006).
   PubMed Web of Science ®Google Scholar
• Klein C, Brown R, Wenning G, Quinn N. The ‘cold hands sign’ in multiple system atrophy. Mov. Disord.>12, 514–518 (1997).
   PubMed Web of Science ®Google Scholar
• Manfredi M, Teive HA, Pedace F, Andrade LA, Ferraz HB, Sa DS, Curra A. C. David Marsden and Rolex sign. Neurol. Sci.>24, 45–46 (2003).
   PubMed Web of Science ®Google Scholar
• Schrag A, Good CD, Miszkiel K et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology>54, 697–702 (2000).
   PubMed Web of Science ®Google Scholar
• Seppi K. MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice. Parkinsonism Relat. Disord.>13(Suppl. 3), S400–S405 (2007).
   Google Scholar
• Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Doring F, Trenkwalder C, Schlossmacher MG. α-synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol.>10, 230–240 (2011).
   PubMed Web of Science ®Google Scholar
• Kollensperger M, Seppi K, Liener C et al. Diffusion weighted imaging best discriminates PD from MSA-P: a comparison with tilt table testing and heart MIBG scintigraphy. Mov. Disord.>22, 1771–1776 (2007).
   PubMed Web of Science ®Google Scholar
• Mahlknecht P, Hotter A, Hussl A, Esterhammer R, Schocke M, Seppi K. Significance of MRI in diagnosis and differential diagnosis of Parkinson’s disease. Neurodegener. Dis.>7, 300–318 (2010).
   PubMed Web of Science ®Google Scholar
• Eller M, Williams DR. Biological fluid biomarkers in neurodegenerative parkinsonism. Nat. Rev. Neurol.>5, 561–570 (2009).
   PubMed Web of Science ®Google Scholar
• Abdo WF, Bloem BR, van Geel WJ, Esselink RA, Verbeek MM. CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson’s disease. Neurobiol. Aging>28, 742–747 (2007).
   PubMed Web of Science ®Google Scholar
• Constantinescu R, Rosengren L, Johnels B, Zetterberg H, Holmberg B. Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson’s disease and atypical Parkinsonian disorders. Parkinsonism Relat. Disord.>16, 142–145 (2010).
   PubMed Web of Science ®Google Scholar
• Constantinescu R, Zetterberg H, Holmberg B, Rosengren L. Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders. Parkinsonism Relat. Disord.>15, 205–212 (2009).
   PubMed Web of Science ®Google Scholar